Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells
Open Access
- 1 September 1996
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 7 (7), 719-724
- https://doi.org/10.1093/oxfordjournals.annonc.a010721
Abstract
To evaluate in a multivariate analysis the prognostic factors associated with hematopoietic recovery and the supportive care requirements after autotransplant of progenitor cells (PC) from various sources: bone marrow (BMPC), BMPC & peripheral blood (PBPC), and PBPC alone. A total of 570 patients with hematological malignancies and solid tumors underwent high-dose therapy followed by autotransplant. PBPC were obtained after mobilization with chemotherapy and/or cytokines. One-hundred five patients received BMPC, 217 received BMPC & PBPC and 248 PBPC alone; all of the patients received G-CSF or GM-CSF after infusion. In a multivariate analysis the recovery of neutrophils was adversely associated with low numbers of nucleated cells infused (PPP<.0 01). We conclude that BMPC adversely affect neutrophil recovery while low numbers of nucleated cells and diagnosis of multiple myeloma and acute leukemia adversely affect both neutrophil and platelet recovery.Keywords
This publication has 7 references indexed in Scilit:
- High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.Journal of Clinical Oncology, 1994
- Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphomaBlood, 1994
- Placebo-controlled phase III trial of lenograstim in bone-marrow transplantationThe Lancet, 1994
- High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograftBlood, 1994
- Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapyBlood, 1993
- Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignanciesBlood, 1993
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATIONThe Lancet, 1989